Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Li, Min ^a   Hu, Xiaolan ^a   Fan, Yingli ^a   Li, Kun ^a   Zhang, Xiaowei ^a   Hou, Wenshang ^a   Tang, Zhenyu ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLICATION; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERURICEMIA; MALE; META ANALYSIS; MORBIDITY; MORTALITY; ODDS RATIO; RISK FACTOR;

CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERURICEMIA; MALE; MORBIDITY; MORTALITY; ODDS RATIO; RISK FACTORS;

EID: 84955595265     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19520     Document Type: Article

References (67)

1. Celermajer, D. S., Chow, C. K., Marijon, E., Anstey, N. M., Woo, K. S. Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol. 60, 1207-1216 (2012).
2. Mozaffarian, D. et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 131, e29-322 (2015).
3. Afshin, A., Micha, R., Khatibzadeh, S., Mozaffarian, D. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 100, 278-288 (2014).
4. Mente, A., de Koning, L., Shannon, H. S., Anand, S. S. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 169, 659-669 (2009).
5. Soedamah-Muthu, S. S. et al. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: doseresponse meta-analysis of prospective cohort studies. Am J Clin Nutr. 93, 158-171 (2011).
6. Bomback, A. S. et al. Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int. 77, 609-616 (2010).
7. Becker, B. F. Towards the physiological function of uric acid. Free Radic Biol Med. 14, 615-631 (1993).
8. Sinha, S., Singh, S. N., Ray, U. S. Total antioxidant status at high altitude in lowlanders and native highlanders: role of uric acid. High Alt Med Biol. 10, 269-274 (2009).
9. Becker, M. A. et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med. 353, 2450-2461 (2005).
10. Wheeler, J. G., Juzwishin, K. D., Eiriksdottir, G., Gudnason, V., Danesh, J. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med. 2, e76 (2005).
11. Kim, S. Y. et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 62, 170-180 (2010).
12. Braga, F., Pasqualetti, S., Ferraro, S., Panteghini, M. Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis. Clin Chem Lab Med. (2015). 10.1515/cclm-2015-0523.
13. doi: 10.1515/cclm-2015-0523. 13. Kavousi, M. et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 156, 438-444 (2012).
14. Storhaug, H. M. et al. Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromso Study. BMC Cardiovasc Disord. 13, 115 (2013).
15. Chuang, S. Y., Chen, J. H., Yeh, W. T., Wu, C. C., Pan, W. H. Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort. Int J Cardiol. 154, 316-321 (2012).
16. Zalawadiya, S. K. et al. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III. Eur J Prev Cardiol. 22, 513-518 (2015).
17. Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 283, 2008-2012 (2000).
18. Stang, A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. Eur J Epidemiol. 25, 603-605 (2010).
19. DerSimonian, R., Laird, N. Meta-analysis in clinical trials. Control Clin Trials. 7, 177-188 (1986).
20. Greenland, S., Longnecker, M. P. Methods for trend estimation from summarized dose-response data, with applications to metaanalysis. Am J Epidemiol. 135, 1301-1309 (1992).
21. Berlin, J. A., Longnecker, M. P., Greenland, S. Meta-analysis of epidemiologic dose-response data. Epidemiology. 4, 218-228 (1993).
22. Orsini, N., Li, R., Wolk, A., Khudyakov, P., Spiegelman, D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 175, 66-73 (2012).
23. Harrell, F. E. Jr, Lee, K. L., Pollock, B. G. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 80, 1198-1202 (1988).
24. Higgins, J. P., Thompson, S. G., Deeks, J. J., Altman, D. G. Measuring inconsistency in meta-analyses. BMJ. 327, 557-560 (2003).
25. Higgins, J. P. Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 37, 1158-1160 (2008).
26. Begg, C. B., Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 50, 1088-1101 (1994).
27. Egger, M., Davey, S. G., Schneider, M., Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315, 629-634 (1997).
28. Peters, J. L., Sutton, A. J., Jones, D. R., Abrams, K. R., Rushton, L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 61, 991-996 (2008).
29. Duval, S., Tweedie, R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics. 56, 455-463 (2000).
30. Higgins, J. P. T., Green, S. Cochrane Handbook for systematic Reviews of Interventions. Oxford, UK: The Cochrane Collaboration; (2011).
31. Freedman, D. S., Williamson, D. F., Gunter, E. W., Byers, T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 141, 637-644 (1995).
32. Goldberg, R. J. et al. Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men. 20-year findings from the Honolulu Heart Program. Arch Intern Med. 155, 686-694 (1995).
33. Liese, A. D. et al. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology. 10, 391-397 (1999).
34. Culleton, B. F., Larson, M. G., Kannel, W. B., Levy, D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 131, 7-13 (1999).
35. Moriarity, J. T., Folsom, A. R., Iribarren, C., Nieto, F. J., Rosamond, W. D. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 10, 136-143 (2000).
36. Puddu, P. E. et al. Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study. Acta Cardiol. 56, 243-251 (2001).
37. Chien, K. L. et al. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis. 183, 147-155 (2005).
38. Bos, M. J., Koudstaal, P. J., Hofman, A., Witteman, J. C., Breteler, M. M. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke. 37, 1503-1507 (2006).
39. Krishnan, E., Baker, J. F., Furst, D. E., Schumacher, H. R. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 54, 2688-2696 (2006).
40. Baba, T. et al. Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki. Hypertens Res. 30, 823-829 (2007).
41. Meisinger, C., Koenig, W., Baumert, J., Doring, A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol. 28, 1186-1192 (2008).
42. Levine, W., Dyer, A. R., Shekelle, R. B., Schoenberger, J. A., Stamler, J. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol. 42, 257-267 (1989).
43. Fang, J., Alderman, M. H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 283, 2404-2410 (2000).
44. Tomita, M. et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol. 10, 403-409 (2000).
45. Aboa, E. A. C., De Smet P., Dramaix, M., De Backer, G., Kornitzer, M. [Relation between uricemia and total, cardiovascular and coronary mortality in both genders of non-selected sample of the Belgium population]. Rev Epidemiol Sante Publique. 49, 531-539 (2001).
46. Jee, S. H., Lee, S. Y., Kim, M. T. Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Cardiovasc Prev Rehabil. 11, 185-191 (2004).
47. Hakoda, M. et al. Serum uric acid concentration as a risk factor for cardiovascular mortality: a longterm cohort study of atomic bomb survivors. J Rheumatol. 32, 906-912 (2005).
48. Baibas, N., Trichopoulou, A., Voridis, E., Trichopoulos, D. Residence in mountainous compared with lowland areas in relation to total and coronary mortality. A study in rural Greece. J Epidemiol Community Health. 59, 274-278 (2005).
49. Gerber, Y., Tanne, D., Medalie, J. H., Goldbourt, U. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil. 13, 193-8 (2006).
50. Krishnan, E., Svendsen, K., Neaton, J. D., Grandits, G., Kuller, L. H. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med. 168, 1104-1110 (2008).
51. Strasak, A. et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem. 54, 273-284 (2008).
52. Strasak, A. M. et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol. 125, 232-239 (2008).
53. Holme, I., Aastveit, A. H., Hammar, N., Jungner, I., Walldius, G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 266, 558-570 (2009).
54. Chen, J. H., Chuang, S. Y., Chen, H. J., Yeh, W. T., Pan, W. H. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum. 61, 225-232 (2009).
55. Dutta, A., Henley, W., Pilling, L. C., Wallace, R. B., Melzer, D. Uric acid measurement improves prediction of cardiovascular mortality in later life. J Am Geriatr Soc. 61, 319-326 (2013).
56. Skak-Nielsen, H. et al. Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. PLoS One. 8, e59121 (2013).
57. Savarese, G. et al. Changes in serum uric acid levels and cardiovascular events: a meta-analysis. Nutr Metab Cardiovasc Dis. 23, 707-714 (2013).
58. Zhao, G., Huang, L., Song, M., Song, Y. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis. 231, 61-68 (2013).
59. Li, M., Hou, W., Zhang, X., Hu, L., Tang, Z. Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies. Atherosclerosis. 232, 265-270 (2014).
60. Harris, E. K., Kanofsky, P., Shakarji, G., Cotlove, E. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. II. Estimating biological components of variation. Clin Chem. 16, 1022-1027 (1970).
61. Waring, W. S., Maxwell, S. R., Webb, D. J. Uric acid concentrations and the mechanisms of cardiovascular disease. Eur Heart J. 23, 1888-1889 (2002).
62. Dawson, J., Quinn, T., Walters, M. Uric acid reduction: a new paradigm in the management of cardiovascular risk. Curr Med Chem. 14, 1879-1886 (2007).
63. Ruggiero, C. et al. Uric acid and inflammatory markers. Eur Heart J. 27, 1174-1181 (2006).
64. Tiong, A. Y., Brieger, D. Inflammation and coronary artery disease. Am Heart J. 150, 11-18 (2005).
65. Montalcini, T. et al. Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women. Intern Emerg Med. 2, 19-23 (2007).
66. Lee, Y. et al. Chin-Shan Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol. 53, 838-846 (2000).
67. Torng, P. L. et al. Effects of menopause and obesity on lipid profiles in middle-aged Taiwanese women: the Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis. 153, 413-421 (2000).